Physician profile
George J Azar
NPI 1376632307
$9,282.38
in general payments reported to CMS, 2019-2025
52 companies · $577 in 2025
The $577 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,821 · 2020: $448 · 2021: $408 · 2022: $435 · 2023: $1,159 · 2024: $434 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,170.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,461.68 | 2019-2022 | |
| Davol INC. | $1,002.39 | 2019-2025 | Phasix Mesh |
| Janssen Biotech, INC. | $433.31 | 2019-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $353.35 | 2019-2025 | |
| Allergan, INC. | $253.84 | 2019-2022 | |
| Abbvie INC. | $242.99 | 2020-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Ethicon US, LLC | $151.82 | 2019-2024 | Echelon Flex, Certus 140 |
| Coloplast Corp | $113.74 | 2019-2025 | Titan |
| Tela Bio, INC. | $81.55 | 2019-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Sumitomo Pharma America, INC. | $72.90 | 2023-2025 | Gemtesa |
| Urogen Pharma, INC. | $70.66 | 2022-2023 | Jelmyto |
| Laborie Medical Technologies Corp. | $69.07 | 2023-2025 | |
| Smith+Nephew, INC. | $61.45 | 2019-2025 | Collagenase Santyl |
| Kerecis Limited | $53.77 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Axonics, INC. | $42.67 | 2020-2021 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $40.83 | 2024 | Restrata Wound Matrix |
| Teleflex LLC | $35.01 | 2020-2025 | Urolift |
| Convatec INC. | $34.46 | 2021-2022 | |
| Hologic Sales and Service, LLC | $34.31 | 2023-2025 | Trident Specimen Radiography System, Trunode, Magseed |
| Mission Pharmacal Company | $32.16 | 2023-2024 | Uribel Tabs, Uribel |
| Blue Earth Diagnostics | $31.99 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $29.93 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $29.53 | 2021-2025 | Exparel, Iovera |
| Medtronic, INC. | $28.49 | 2021-2022 | |
| Tempus Ai, INC | $27.88 | 2024 | |
| Shire North American Group INC | $27.78 | 2019 | |
| Baxter Healthcare | $24.51 | 2020 | |
| Progenics Pharmaceuticals, INC. | $23.79 | 2023 | Pylarify |
| Hartmann USA, INC. | $23.61 | 2021 | |
| Kci USA, INC. | $23.43 | 2021 | |
| Accord Healthcare, INC. | $22.86 | 2025 | |
| Dendreon Pharmaceuticals LLC | $22.77 | 2020 | |
| Integra Lifesciences Corporation | $22.20 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Hollister Incorporated | $21.49 | 2021 | |
| Antares Pharma, INC. | $20.44 | 2019 | |
| Reprise Biomedical, INC. | $19.98 | 2025 | Miro3d |
| Mallinckrodt Hospital Products INC. | $19.00 | 2021 | |
| Civco Medical Instruments | $17.83 | 2024 | |
| Standard Bariatrics, INC. | $17.65 | 2022 | |
| Olympus America INC. | $16.81 | 2023 | Itind System |
| Endo Pharmaceuticals INC. | $16.80 | 2023 | Xiaflex, Aveed |
| Endo USA, INC. | $16.68 | 2025 | Xiaflex, Aveed |
| Thd America, INC. | $15.89 | 2025 | |
| Bard Peripheral Vascular, INC. | $15.88 | 2021 | |
| Travere Therapeutics, INC. | $15.70 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.49 | 2021 | |
| Organogenesis INC. | $15.14 | 2022 | |
| Tolmar, INC. | $14.29 | 2025 | Eligard, Jatenzo |
| Astellas Pharma US INC | $13.36 | 2024 | Xtandi |
| Covidien LP | $12.65 | 2019 | |
| Medela LLC | $9.93 | 2020 | |
| Ambu INC. | $6.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Azar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.